| 000 | 01704 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513045726.0 | ||
| 264 | 0 | _c19950314 | |
| 008 | 199503s 0 0 eng d | ||
| 022 | _a0006-291X | ||
| 024 | 7 |
_a10.1006/bbrc.1995.1154 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMizutani, Y | |
| 245 | 0 | 0 |
_aInduction of erythroid differentiation in leukaemic K562 cells by an S-adenosylhomocysteine hydrolase inhibitor, aristeromycin. _h[electronic resource] |
| 260 |
_bBiochemical and biophysical research communications _cFeb 1995 |
||
| 300 |
_a69-74 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a3T3 Cells |
| 650 | 0 | 4 |
_aAdenosine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAdenosylhomocysteinase |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aCell Line, Transformed |
| 650 | 0 | 4 | _aCell Transformation, Neoplastic |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aFormycins _xpharmacology |
| 650 | 0 | 4 | _aGenes, abl |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrolases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aIsomerism |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aLeukemia, Erythroblastic, Acute |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aTubercidin _xpharmacology |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aMasuoka, S | |
| 700 | 1 | _aImoto, M | |
| 700 | 1 | _aKawada, M | |
| 700 | 1 | _aUmezawa, K | |
| 773 | 0 |
_tBiochemical and biophysical research communications _gvol. 207 _gno. 1 _gp. 69-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/bbrc.1995.1154 _zAvailable from publisher's website |
| 999 |
_c7856644 _d7856644 |
||